J. Andrew Case, also known as Andy, is the Head of Supply Chain for Cell & Gene Therapies at Genentech/Roche. With an MBA from IMD, he is an expert in individualized therapies, previously managing the business solution for the first-to-market CAR-T therapy at Novartis. Colleagues describe him as having a "clear vision" and a "can-do style".
He recently discussed the critical supply chain challenges for new autologous mRNA cancer vaccines, where a patient receiving the wrong vaccine could be fatal due to non-response.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.